We established a five-gene signature (CCNB2, CDC20, NUSAP1, ASPM, and NCAPG) to predict overall survival of HCC, which may contribute to the clinical decision-making of HCC treatment for different individuals. Here, CCNB2 is linked to hepatocellular carcinoma.